|
2025 Conference Publication D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffoldWood, James, Ghosh, Saikat, Houston, Zachary, Fletcher, Nicholas, Humphries, James, Mardon, Karine, Akhter, Dewan, Tieu, William, Ivashkevich, Alesia, Wheatcroft, Michael, Thurecht, Kristofer and Codd, Rachel (2025). D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109244 |
|
2025 Conference Publication Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challengesHuda, Pie, Owen, David, Bell, Craig, Wood, James, Humphries, James and Thurecht, Kristofer (2025). Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challenges. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109460 |
|
2025 Conference Publication Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloadsFletcher, Nicholas, Thurecht, Kristofer, Chu, Weijing, Huda, Pie, Humphries, James and Wood, James (2025). Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloads. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109150 |
|
2025 Journal Article An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelatorsNolan, Kate P., Rosser, Callum A., Wood, James L., Font, Josep, Sresutharsan, Athavan, Wang, Joseph, Markham, Todd E., Ryan, Renae M. and Codd, Rachel (2025). An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelators. Chemical Science, 16 (5), 2180-2190. doi: 10.1039/d4sc04888a |
|
2024 Journal Article A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elementsWood, James Liam, Ghosh, Saikat, Houston, Zachary, Fletcher, Nicholas, Humphries, James, Mardon, Karine, Akhter, Dewan T., Tieu, William, Ivashkevich, Alesia, Wheatcroft, Michael P., Thurecht, Kristofer J. and Codd, Rachel (2024). A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements. Chemical Science, 15 (30), 11748-11760. doi: 10.1039/d4sc02851a |
|
2023 Journal Article Reduction-cleavable desferrioxamine B pulldown system enriches Ni(II)-superoxide dismutase from a Streptomyces proteomeNi, Jenny, Wood, James L., White, Melanie, Lihi, Norbert, Markham, Todd E., Wang, Joseph, Chivers, Peter and Codd, Rachel (2023). Reduction-cleavable desferrioxamine B pulldown system enriches Ni(II)-superoxide dismutase from a Streptomyces proteome. RSC Chemical Biology, 4 (12), 1064-1072. doi: 10.1039/d3cb00097d |
|
2022 Other Outputs Ligands and their useCodd, Rachel, Wood, James Liam and Brown, Christopher John McCormack (2022). Ligands and their use. WO2022133537. |
